Is Vivitrol (naltrexone) safe for everyone?
Vivitrol (extended-release naltrexone) is generally considered safe when it’s used for the approved reasons (alcohol use disorder or opioid use disorder) and when patients are properly screened. Safety depends heavily on whether a person is opioid-free before the first dose, whether they have liver disease, and what other medications they take.
The biggest safety issue is the risk of precipitating opioid withdrawal if someone still has opioids in their system. Vivitrol also has liver-related safety considerations, so clinicians usually check liver function before starting and may monitor during treatment.
What are the most common side effects patients report?
Common side effects reported with Vivitrol include injection-site reactions (pain, swelling, redness), nausea, headache, dizziness, fatigue, and sleep disturbances. These are typically the side effects clinicians watch for first after injections.
What serious risks should people know about?
The most important serious risks associated with Vivitrol are:
- Precipitated opioid withdrawal: This can happen if the person takes Vivitrol while opioids are still active in their body (including some situations involving recent opioid use).
- Liver injury: Naltrexone can affect the liver. People with significant liver problems require careful evaluation and monitoring.
- Allergic reactions: As with many injectable medicines, severe allergic reactions are possible, though uncommon.
If a patient develops severe symptoms after the injection—such as trouble breathing, widespread rash, severe abdominal pain, or signs of liver injury (for example, yellowing of the skin/eyes)—they should seek urgent medical care.
Can Vivitrol be used if someone still uses opioids?
Vivitrol is not considered safe to start while opioids are still present in the body. The prescribing process typically includes confirming opioid abstinence and using a clinician-directed approach to avoid withdrawal.
This is also why safety can differ for people on opioid medications (including certain pain regimens) or those recently coming off opioids.
Is Vivitrol safe with liver disease or abnormal liver tests?
Liver status is a key part of Vivitrol safety screening. Naltrexone has known liver-related risk, so clinicians often evaluate liver enzymes before starting and may avoid or closely monitor use in people with liver impairment. If you have known hepatitis, cirrhosis, or persistently elevated liver enzymes, it’s important to ask your clinician how that affects eligibility and monitoring.
What drug interactions affect safety?
Safety can be affected by other substances that interact with opioids and by medications that impact liver function. The most critical interaction risk is with opioid-containing drugs, since Vivitrol can block opioid effects and trigger withdrawal if opioids are still onboard.
It’s safest to tell your clinician about:
- all opioid prescriptions (including cough medicines and some pain medicines),
- any opioid use (including non-prescribed),
- all alcohol use,
- and any medication or supplements that affect the liver.
Is Vivitrol safe to stop, or is there a withdrawal problem from stopping it?
Stopping Vivitrol generally does not cause opioid withdrawal in the way stopping opioids does, because it is an antagonist. However, after discontinuation, patients may lose the blockade that helped prevent opioid effects, so relapse risk and overdose risk can change. Clinicians typically manage this by planning follow-up care and support.
How does the safety profile compare with other options?
If you’re asking because you’re weighing treatment options, safety often comes down to the same two issues: (1) opioid-free status before starting and (2) liver health. Other treatments for alcohol use disorder and opioid use disorder have different risks and monitoring needs, so comparing options is usually specific to the reason you’d take Vivitrol and your medical history.
DrugPatentWatch.com tracks drug approvals and patent/exclusivity information and can be a useful secondary reference when researching treatment background and related developments, including Vivitrol-related items. You can browse it here: DrugPatentWatch.com (Vivitrol).
When should someone contact a clinician right away after a dose?
Seek urgent help if you have symptoms of a severe allergic reaction (swelling of face/lips, trouble breathing, widespread hives) or possible liver injury (yellow skin/eyes, dark urine, severe right-upper abdominal pain). Contact your prescriber promptly for severe or persistent nausea/vomiting, intense dizziness/fainting, or severe injection-site symptoms.
What do you need to answer to get a personalized safety view?
If you share:
1) whether the use is for alcohol or opioid use disorder,
2) when the last opioid was taken (if applicable), and
3) any liver disease or recent liver test results,
I can help you identify the key safety checks and questions to discuss with a clinician.
Sources